Main Article Content
Abstract
Article Details
References
- Salem M. Kholoussi S.Κholoussi N.Fawzy R.Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus.Archives of hellenic med. 2011;28(1):83-88.
- Nakhjavani M, Esteghamati A, Nowroozi S, Asgarani F, Rashidi A, Khalilzadeh O.Type 2 diabetes mellitus duration: an independent predictor of serum malondialdehyde levels.Singapore Med J 2010; 51(7) : 582-585.
- Slatter D.A. Bolton C.H. Bailey A.J.The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43: 550-557.
- SuryawanshiN.P. BhuteyA.K. NagdeoteA.N. JadhavA.A. ManoorkarG.S.study of lipid peroxide and lipid profile in diabetes mellitus. Indian J of ClinlBiochemy 2006; 21 (1) :126-130.
- Galli, F.; Piroddi, M.; Annetti, C.; Aisa, C.; Floridi, E.; Floridi, A. Oxidative stress and reactive oxygen species. Contrib. Nephrol., 2005;149: 240-260.
- Gambhir, J. K.; Lali, P.; Jain, A. K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis.Clin.Biochem.,1997; 30(4): 351-355.
- Hitchon, C. A.; El Gabalawy, H. S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther., 2004;6(6),:265-278.
- Kamanli, A.; Naziroglu, M.; Aydilek, N.; Hacievliyagil, C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem.Funct.,2004;22(1): 53-57.
- Shaabani, Y.; Foroughi, M; Rastmanesh, R; Jamshidi, A; Tajik, N; Assadi, O. Assessment of antioxidant nutrient intake and Malondiadehyde plasma level in rheumatoid arthritis. ARYA Atherosclerosis J.2009; 5(1): 1-5.
- Quinn L. Behavior and biology: The prevention of type 2 diabetes. J CardiovascNurs 2003;18:62−68.
- Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes DevCtries 2010;30:49−51.
- Panasenko, O. M.; Vol'nova, T. V.; Azizova, O. A.; Vladimirov, Y. A. Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis. Free Radic. Biol. Med., 1991,;10(2):137-148.
- Scott DL, Symmons DP, Coulton BL, PopertAJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108–11.
- Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis,and causes of death in rheumatoid arthritis.Arthritis Rheum1986;29:706–14.
- Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864–72.
- Isomaki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl 1992;95:3–8.
- Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl 1996;44:13–22
- Paredes, S.; Girona, J.; Hurt-Camejo, E.; Vallve, J. C.; Olive, S.; Heras, M.; Benito, P.; Masana, L. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: Association with inflammatory markers. J. Rheumatol., 2002; 29(11):2271-2277.
- Joan H. P. Robert B.Z. David A.L.Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukocyte Biol.2007;81:1-8.
- Satoh, K. Serum lipid peroxide in cerebrovascular disorder determined by new colorimetric method. Clin.Chim.Acta 1978;90,:37-43.
- WULF, D. Free radicals in the physiological control of cell function. Physiol Rev.2002;82: 47–95.
- jain SK:Hyperglycemia can causes membrane lipid peroxidation and asmotic fragility in human red blood cells.J.Boil.Chem.1989;264:21340-21345.
- Wierusz-Wysooka B,Wysocki H,Wyks H:Metabolic control aulity and free radicals activity in diabetic patients.Diabetetes res.Clin.Pract.1995;72. 193-207.
- Nevi S,Bruno CM,Raciti C and Angelo B:altration of oxide reductive and harmostic factor in type 2diabetes J.Inter.Med.,1994;236(5):495-500.
- Sarban, S.; Kocyigit, A.; Yazar, M.; Isikan, U. E. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients
- Cotraneo P,Manto A,Todaro L,and Magnant p:Hyper filtration in patient with diabetes mellitus:a prevalence study:Clin Nephrol.1998;50:214-217.
- Erdberg A,boner G,Van Dyck DJ and Care R:Uric acid excretion in patient with non-insulin dependent diabetes mellitus nephron,1992;60:134-137.
- Gonzalez-Sicilia L,Garcia-Estan J,Martinez-Blazguez A and Frnandez-pardo J:Renal metabolism of uric acid in type 1 insulin dependent diabetic patient:Horm.Meta.Res.1997;29:520-523.
- Sinclair AJ,Lunec,Girling AJ and Barnett AH:Modulatores of free radical activity in diabetes mellitus:Rol of ascorbic acid.EXS.1992;62:342-352.
References
Salem M. Kholoussi S.Κholoussi N.Fawzy R.Malondialdehyde and trace element levels in patients with type 2 diabetes mellitus.Archives of hellenic med. 2011;28(1):83-88.
Nakhjavani M, Esteghamati A, Nowroozi S, Asgarani F, Rashidi A, Khalilzadeh O.Type 2 diabetes mellitus duration: an independent predictor of serum malondialdehyde levels.Singapore Med J 2010; 51(7) : 582-585.
Slatter D.A. Bolton C.H. Bailey A.J.The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000; 43: 550-557.
SuryawanshiN.P. BhuteyA.K. NagdeoteA.N. JadhavA.A. ManoorkarG.S.study of lipid peroxide and lipid profile in diabetes mellitus. Indian J of ClinlBiochemy 2006; 21 (1) :126-130.
Galli, F.; Piroddi, M.; Annetti, C.; Aisa, C.; Floridi, E.; Floridi, A. Oxidative stress and reactive oxygen species. Contrib. Nephrol., 2005;149: 240-260.
Gambhir, J. K.; Lali, P.; Jain, A. K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis.Clin.Biochem.,1997; 30(4): 351-355.
Hitchon, C. A.; El Gabalawy, H. S. Oxidation in rheumatoid arthritis. Arthritis Res. Ther., 2004;6(6),:265-278.
Kamanli, A.; Naziroglu, M.; Aydilek, N.; Hacievliyagil, C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem.Funct.,2004;22(1): 53-57.
Shaabani, Y.; Foroughi, M; Rastmanesh, R; Jamshidi, A; Tajik, N; Assadi, O. Assessment of antioxidant nutrient intake and Malondiadehyde plasma level in rheumatoid arthritis. ARYA Atherosclerosis J.2009; 5(1): 1-5.
Quinn L. Behavior and biology: The prevention of type 2 diabetes. J CardiovascNurs 2003;18:62−68.
Mahreen R, Mohsin M, Nasreen Z, Siraj M, Ishaq M. Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. Int J Diabetes DevCtries 2010;30:49−51.
Panasenko, O. M.; Vol'nova, T. V.; Azizova, O. A.; Vladimirov, Y. A. Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis. Free Radic. Biol. Med., 1991,;10(2):137-148.
Scott DL, Symmons DP, Coulton BL, PopertAJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108–11.
Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis,and causes of death in rheumatoid arthritis.Arthritis Rheum1986;29:706–14.
Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864–72.
Isomaki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl 1992;95:3–8.
Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl 1996;44:13–22
Paredes, S.; Girona, J.; Hurt-Camejo, E.; Vallve, J. C.; Olive, S.; Heras, M.; Benito, P.; Masana, L. Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: Association with inflammatory markers. J. Rheumatol., 2002; 29(11):2271-2277.
Joan H. P. Robert B.Z. David A.L.Analysis of the thiol status of peripheral blood leukocytes in rheumatoid arthritis patients. J Leukocyte Biol.2007;81:1-8.
Satoh, K. Serum lipid peroxide in cerebrovascular disorder determined by new colorimetric method. Clin.Chim.Acta 1978;90,:37-43.
WULF, D. Free radicals in the physiological control of cell function. Physiol Rev.2002;82: 47–95.
jain SK:Hyperglycemia can causes membrane lipid peroxidation and asmotic fragility in human red blood cells.J.Boil.Chem.1989;264:21340-21345.
Wierusz-Wysooka B,Wysocki H,Wyks H:Metabolic control aulity and free radicals activity in diabetic patients.Diabetetes res.Clin.Pract.1995;72. 193-207.
Nevi S,Bruno CM,Raciti C and Angelo B:altration of oxide reductive and harmostic factor in type 2diabetes J.Inter.Med.,1994;236(5):495-500.
Sarban, S.; Kocyigit, A.; Yazar, M.; Isikan, U. E. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients
Cotraneo P,Manto A,Todaro L,and Magnant p:Hyper filtration in patient with diabetes mellitus:a prevalence study:Clin Nephrol.1998;50:214-217.
Erdberg A,boner G,Van Dyck DJ and Care R:Uric acid excretion in patient with non-insulin dependent diabetes mellitus nephron,1992;60:134-137.
Gonzalez-Sicilia L,Garcia-Estan J,Martinez-Blazguez A and Frnandez-pardo J:Renal metabolism of uric acid in type 1 insulin dependent diabetic patient:Horm.Meta.Res.1997;29:520-523.
Sinclair AJ,Lunec,Girling AJ and Barnett AH:Modulatores of free radical activity in diabetes mellitus:Rol of ascorbic acid.EXS.1992;62:342-352.
